Clinical Trials for Drug: INC280

1 Open Trials. Phone:(877.827.8839)
Protocol No. Title Status
UCI-15-82 A phase II, multicenter, study of oral cMET inhibitor INC280 in adult patients with EGFR wild-type (wt), advanced non-small cell lung cancer (NSCLC) Open